ISSC stock news
This page provides real-time market news, earnings updates, and company announcements related to Innovative Solutions and Support, Inc. (ISSC).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-19 08:03 EST
EXCLUSIVE: Norfolk Southern and CMA CGM introduce innovative intermodal service designed to rival trucking
101 finance2026-02-18 17:06:16

Can Ciena Sustain Growth on Rising Optical and Data Demand?
Finviz2026-02-18 17:21:43

Can Commercial Metals' TAG Program Drive Margin Expansion?
Finviz2026-02-18 17:39:39

Why the CEO of Bauch + Lomb is linking employee salaries to their understanding of AI
101 finance2026-02-18 18:27:11

Amazon suspends Blue Jay robotics initiative after operating for under half a year
101 finance2026-02-18 18:57:36

Remitly Appoints Sebastian J. Gunningham as Chief Executive Officer
Finviz2026-02-18 21:09:41

Sight Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
Finviz2026-02-18 21:09:41
DoorDash reports robust quarterly increases in both sales and orders, yet cautions about significant expenses ahead
101 finance2026-02-18 21:24:38

Jack in the Box (NASDAQ:JACK) Misses Q4 CY2025 Sales Expectations
Finviz2026-02-18 21:42:37

Bullish Analyst Opinion on Dyne (DYNE) Follows Rare Disease Drug Progress in Japan
Finviz2026-02-19 00:39:37

Jeffries Highlight Cybin D/B/A Helus Pharma (HELP)'s Science-Driven Psilocybin Therapies as Key Growth Drivers
Finviz2026-02-19 02:30:37

RBC Capital Cite GH Research PLC's (GHRS) Long-Term Sales Potential Following Psychedelics Symposium
Finviz2026-02-19 02:33:44

Needham Bullish on Neurocrine Biosciences, Inc. (NBIX) Pipeline Amid 2026 Growth Expectations for Crenessity and Ingrezza
Finviz2026-02-19 02:36:45

Teck Reports Unaudited Fourth Quarter Results for 2025
Finviz2026-02-19 06:06:04
5 Thought-Provoking Analyst Inquiries From Flowers Foods’s Fourth Quarter Earnings Discussion
101 finance2026-02-19 10:03:37
5 Insightful Analyst Inquiries from Applied Materials’ Fourth Quarter Earnings Conference
101 finance2026-02-19 10:18:41
Investment bank Piper Sandler recently announced its initial coverage of medical technology company Perspective Therapeutics (stock code: CATX), assigning an "Overweight" rating.
老虎证券2026-02-19 10:37:31
5 Thought-Provoking Analyst Inquiries from West Pharmaceutical Services’ Fourth Quarter Earnings Discussion
101 finance2026-02-19 10:36:51

YETI Announces CFO Transition
Finviz2026-02-19 11:03:47

Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Financial Results
Finviz2026-02-19 12:03:41

NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform
Finviz2026-02-19 12:03:42
Regeneron Pharmaceuticals announced that its Biologics License Application (BLA) for Garetosmab, a treatment for fibrodysplasia ossificans progressiva (FOP), has been accepted by the U.S. Food and Drug Administration (FDA) and granted priority review status.
老虎证券2026-02-19 12:11:51

Cardiff Oncology to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Finviz2026-02-19 12:03:42

Jeffs' Brands: KeepZone AI Enters into Distribution Agreement with Assac Networks to Distribute Cybersecurity Software
Finviz2026-02-19 12:36:41

Amazon suspends Blue Jay robotics initiative after operating for under half a year
101 finance2026-02-18 18:57:36

Remitly Appoints Sebastian J. Gunningham as Chief Executive Officer
Finviz2026-02-18 21:09:41

Sight Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
Finviz2026-02-18 21:09:41
DoorDash reports robust quarterly increases in both sales and orders, yet cautions about significant expenses ahead
101 finance2026-02-18 21:24:38

Jack in the Box (NASDAQ:JACK) Misses Q4 CY2025 Sales Expectations
Finviz2026-02-18 21:42:37

Bullish Analyst Opinion on Dyne (DYNE) Follows Rare Disease Drug Progress in Japan
Finviz2026-02-19 00:39:37

Jeffries Highlight Cybin D/B/A Helus Pharma (HELP)'s Science-Driven Psilocybin Therapies as Key Growth Drivers
Finviz2026-02-19 02:30:37

RBC Capital Cite GH Research PLC's (GHRS) Long-Term Sales Potential Following Psychedelics Symposium
Finviz2026-02-19 02:33:44

Needham Bullish on Neurocrine Biosciences, Inc. (NBIX) Pipeline Amid 2026 Growth Expectations for Crenessity and Ingrezza
Finviz2026-02-19 02:36:45

Teck Reports Unaudited Fourth Quarter Results for 2025
Finviz2026-02-19 06:06:04
5 Thought-Provoking Analyst Inquiries From Flowers Foods’s Fourth Quarter Earnings Discussion
101 finance2026-02-19 10:03:37
5 Insightful Analyst Inquiries from Applied Materials’ Fourth Quarter Earnings Conference
101 finance2026-02-19 10:18:41
Investment bank Piper Sandler recently announced its initial coverage of medical technology company Perspective Therapeutics (stock code: CATX), assigning an "Overweight" rating.
老虎证券2026-02-19 10:37:31
5 Thought-Provoking Analyst Inquiries from West Pharmaceutical Services’ Fourth Quarter Earnings Discussion
101 finance2026-02-19 10:36:51

YETI Announces CFO Transition
Finviz2026-02-19 11:03:47

Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Financial Results
Finviz2026-02-19 12:03:41

NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform
Finviz2026-02-19 12:03:42
Regeneron Pharmaceuticals announced that its Biologics License Application (BLA) for Garetosmab, a treatment for fibrodysplasia ossificans progressiva (FOP), has been accepted by the U.S. Food and Drug Administration (FDA) and granted priority review status.
老虎证券2026-02-19 12:11:51

Cardiff Oncology to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Finviz2026-02-19 12:03:42

Jeffs' Brands: KeepZone AI Enters into Distribution Agreement with Assac Networks to Distribute Cybersecurity Software
Finviz2026-02-19 12:36:41
ISSC stock chart
ISSC stock detailsISSC stock price change
On the last trading day, ISSC stock closed at 19.83 USD, with a price change of -4.53% for the day.
Trade stock futuresAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more